WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TXG

Based on 9 analysts offering 12 month price targets for 10x Genomics Inc

Min Forecast
$14.00-29.82%
Avg Forecast
$18.44-7.55%
Max Forecast
$22.00+10.28%

Should I buy or sell TXG stock?

Based on 9 analysts offering ratings for 10x Genomics Inc.

Buy
Strong Buy
2 analysts 22.22%
Buy
0 analysts 0%
Hold
7 analysts 77.78%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TXG's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates TXG as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TXG stock forecasts and price targets.

TXG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-27
lockedlocked$00.00+00.00%2026-01-07
lockedlocked$00.00+00.00%2025-12-22
lockedlocked$00.00+00.00%2025-12-15
lockedlocked$00.00+00.00%2025-12-11
Morgan Stanley
Bottom 9%
9
HoldDowngrades$20.00+0.25%2025-12-02
Piper Sandler
Top 5%
96
HoldMaintains$19.00-4.76%2025-11-11
JP Morgan
Bottom 4%
4
HoldMaintains$15.00-24.81%2025-11-07
UBS
Top 11%
90
HoldMaintains$14.00-29.82%2025-11-07

1 of 1

Forecast return on equity

Is TXG forecast to generate an efficient return?

Company
4.07%
Industry
23.56%
Market
213.28%
TXG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TXG forecast to generate an efficient return on assets?

Company
3.11%
Industry
19.9%
TXG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TXG earnings per share forecast

What is TXG's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
-$0.96
Avg 2 year Forecast
-$0.69
Avg 3 year Forecast
$0.00

TXG revenue forecast

What is TXG's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$617.8M-3.74%
Avg 2 year Forecast
$668.7M+4.19%
Avg 3 year Forecast
$726.6M+13.21%
TXG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TXG revenue growth forecast

How is TXG forecast to perform vs Health Information Services companies and vs the US market?

Company
4.12%
Industry
10.2%
Market
23.15%
TXG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TXG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TXG vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
TXG$19.95$18.44-7.55%Buy
HTFL$28.78$39.20+36.21%Strong Buy
HNGE$35.23$63.39+79.92%Strong Buy
WGS$99.01$167.00+68.67%Strong Buy
OMCL$48.70$54.60+12.11%Strong Buy
View Top Health Information Service Stocks

10x Genomics Stock Forecast FAQ

Is 10x Genomics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: TXG) stock is to Buy TXG stock.

Out of 9 analysts, 2 (22.22%) are recommending TXG as a Strong Buy, 0 (0%) are recommending TXG as a Buy, 7 (77.78%) are recommending TXG as a Hold, 0 (0%) are recommending TXG as a Sell, and 0 (0%) are recommending TXG as a Strong Sell.

If you're new to stock investing, here's how to buy 10x Genomics stock.

What is TXG's earnings growth forecast for 2026-2028?

(NASDAQ: TXG) 10x Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 35.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.9%.

10x Genomics's earnings in 2026 is -$76,320,000.On average, 19 Wall Street analysts forecast TXG's earnings for 2026 to be -$120,972,061, with the lowest TXG earnings forecast at -$148,826,388, and the highest TXG earnings forecast at -$70,426,773. On average, 15 Wall Street analysts forecast TXG's earnings for 2027 to be -$87,207,707, with the lowest TXG earnings forecast at -$122,781,770, and the highest TXG earnings forecast at -$20,729,390.

In 2028, TXG is forecast to generate $0 in earnings, with the lowest earnings forecast at $0 and the highest earnings forecast at $0.

What is TXG's revenue growth forecast for 2026-2028?

(NASDAQ: TXG) 10x Genomics's forecast annual revenue growth rate of 4.12% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.15%.

10x Genomics's revenue in 2026 is $641,814,000.On average, 18 Wall Street analysts forecast TXG's revenue for 2026 to be $78,184,474,908, with the lowest TXG revenue forecast at $73,917,106,028, and the highest TXG revenue forecast at $83,528,810,252. On average, 14 Wall Street analysts forecast TXG's revenue for 2027 to be $84,624,759,673, with the lowest TXG revenue forecast at $78,443,908,662, and the highest TXG revenue forecast at $93,398,682,699.

In 2028, TXG is forecast to generate $91,953,446,857 in revenue, with the lowest revenue forecast at $83,368,087,877 and the highest revenue forecast at $101,919,499,623.

What is TXG's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TXG) forecast ROA is 3.11%, which is lower than the forecast US Health Information Services industry average of 19.9%.

What is TXG's Price Target?

According to 9 Wall Street analysts that have issued a 1 year TXG price target, the average TXG price target is $18.44, with the highest TXG stock price forecast at $22.00 and the lowest TXG stock price forecast at $14.00.

On average, Wall Street analysts predict that 10x Genomics's share price could fall to $18.44 by Jan 27, 2027. The average 10x Genomics stock price prediction forecasts a potential downside of 7.55% from the current TXG share price of $19.95.

What is TXG's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TXG) 10x Genomics's current Earnings Per Share (EPS) is -$0.63. On average, analysts forecast that TXG's EPS will be -$0.96 for 2026, with the lowest EPS forecast at -$1.18, and the highest EPS forecast at -$0.56. On average, analysts forecast that TXG's EPS will be -$0.69 for 2027, with the lowest EPS forecast at -$0.97, and the highest EPS forecast at -$0.16. In 2028, TXG's EPS is forecast to hit $0.00 (min: $0.00, max: $0.00).

What is TXG's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TXG) forecast ROE is 4.07%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.